13F HOLDINGS REPORT
Propel Bio Management, LLC
Quarter ended Q4 2025 · Filed February 11, 2026 · Accession 0000898432-26-000087
Total Value
$117.1M
Positions
20
Other Managers
1
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PLAINS GP HLDGS L P | PAGP | 1,272,360 | $24.4M | 20.79% |
| 2 | ACHIEVE LIFE SCIENCES INC | ACHV | 3,786,425 | $18.8M | 16.07% |
| 3 | PHATHOM PHARMACEUTICALS INC | PHAT | 740,918 | $12.3M | 10.49% |
| 4 | VIRIDIAN THERAPEUTICS INC | VRDN | 282,531 | $8.8M | 7.51% |
| 5 | MILESTONE PHARMACEUTICALS | MIST | 4,118,321 | $8.3M | 7.10% |
| 6 | KYVERNA THERAPEUTICS INC | KYTX | 666,666 | $6.3M | 5.35% |
| 7 | COMPASS PATHWAYS PLC | CMPS | 861,778 | $5.9M | 5.08% |
| 8 | INVENTIVA SA - ADR | IVEVF | 1,000,000 | $4.7M | 3.97% |
| 9 | DELCATH SYSTEMS INC | DCTH | 438,509 | $4.4M | 3.78% |
| 10 | ABEONA THERAPEUTICS INC | ABEO | 830,780 | $4.4M | 3.74% |
| 11 | CELLDEX THERAPEUTICS INC | CLDX | 154,300 | $4.2M | 3.58% |
| 12 | NEKTAR THERAPEUTICS | NKTR | 82,822 | $3.5M | 2.99% |
| 13 | OCULIS HOLDING AG | OCSAW | 172,839 | $3.5M | 2.95% |
| 14 | SAB BIOTHERAPEUTICS INC | SABSW | 652,881 | $2.4M | 2.08% |
| 15 | REGENXBIO INC | RGNX | 116,896 | $1.7M | 1.44% |
| 16 | ATHIRA PHARMA INC | 04746L203 | 149,279 | $1.1M | 0.96% |
| 17 | LENZ THERAPEUTICS INC | LENZ | 59,085 | $945,360 | 0.81% |
| 18 | AARDVARK THERAPEUTICS INC | AARD | 46,408 | $609,105 | 0.52% |
| 19 | ZEVRA THERAPEUTICS INC | ZVRA | 63,683 | $570,600 | 0.49% |
| 20 | KALARIS THERAPEUTICS INC | KLRS | 42,053 | $354,927 | 0.30% |